UBX Unity Biotechnology Inc

Unity Biotechnology Inc operates as a biotechnology company. The firm focuses on age-associated diseases such as arthritis, vision loss and cognitive decline.

$4.15  +0.05 (1.22%)
As of 03/24/2023 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/03/2018
Outstanding shares:  14,339,119
Average volume:  235,262
Market cap:   $58,790,388
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDT5LR0

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%